Company Name | Astonea Labs Limited |
Company Type | SME |
Sector | Pharma & Cosmetics |
Promoter Holding – Pre IPO | 98.42% |
Promoter Holding – Post IPO | 72.29% |
Dilution (%) | 26.13% |
Fresh Issue | 27,90,000 Shares – INR 37.67 Cr |
Offer size | INR 37.67 Cr |
Price Band | INR 128-135 per share |
Cost of One Lot | INR 1,35,000 |
No. of share Post-IPO | 1,05,11,000 Shares |
Market Cap | INR 142 Cr |
FY22 Profit | INR 0.2 Cr |
FY23 Profit | INR 0.6 Cr |
FY24 Profit | INR 3.8 Cr |
9MFY25 Profit | INR 4.1 Cr. |
P/E | 28x |
Last Year Sales Growth | 16% |
Opening Date | 27-05-2025 |
Closing Date | 29-05-2025 |
Listing Date | 03-05-2025 |
OFS | – |
Website | https://astonea.org/ |
DRHP | https://astonea.org/images/reports/DRHP.pdf |
Question 1: What is the overview of the Company?
Astonea Labs Limited is a Haryana-based pharmaceutical and cosmeceutical manufacturing company with over 35 years of industry experience. The company specializes in third-party manufacturing of a wide range of products, including tablets, capsules, softgels, powders, ointments, creams, and lotions, adhering to stringent quality standards.
Operating from a state-of-the-art facility in Raipur Rani, Panchkula district, Astonea Labs is certified with WHO-GMP, ISO 9001, ISO 22000, CE, PETA, HALAL, and ECO CERT, ensuring compliance with international regulatory standards. The company emphasizes sustainable manufacturing practices, including a zero-liquid discharge facility and resource recycling methods.
Astonea Labs’ core business encompasses contract manufacturing and formulation development, offering customized solutions in pharmaceuticals and cosmeceuticals. The company also engages in the development of proprietary branded products, aiming to build sustainable brands with global reach.
With a dedicated R&D team, Astonea Labs focuses on innovation in product development, including novel molecules and advanced packaging solutions. The company’s commitment to quality and client-centric services positions it as a trusted partner in the pharmaceutical and cosmetic manufacturing sectors.
Business Model:

Products under their own brands

Products under Contract Manufacturing:

Capacity and Capacity Utilization:

Cosmetics:

Question 2 : Who are the promoter of the company?
Ashish Gulati is the Founder and Managing Director of Astonea Labs Limited. With a background in motorsport engineering from Oxford Brookes University, UK, he brings a unique blend of technical expertise and visionary leadership to the company. Under his guidance, Astonea Labs has evolved into a prominent player in the pharmaceutical and cosmeceutical manufacturing industry, known for its commitment to quality, innovation, and customer-centric solutions.
In addition to Ashish Gulati, the company’s board includes other key members:
- Pradeep Singh, Director: Manages the supply chain, leveraging his diploma in pharmacy from Punjab University, Chandigarh, and extensive experience in the pharmaceutical industry.
- Pooja Singh, Director: Heads the Drug Regulatory Affairs (DRA) department, ensuring compliance and quality standards, with a B. Pharma from Rajeev Gandhi College of Pharmacy and 8 years of experience in Quality Assurance and Drug Regulatory Affairs.
- Karan Vir Bindra, Independent Director: Brings additional oversight and governance to the board, with experience in the health services and technology sectors.
This leadership team collectively drives Astonea Labs’ mission to deliver high-quality pharmaceutical and cosmeceutical products, fostering growth and innovation within the industry.
Question 3: How Company performed in the past?
Particular (INR Cr) | FY22 | FY23 | FY24 | 9MFY25 |
Total Revenue | 30 | 67 | 80 | 69.5 |
Net Profit | 0.2 | 0.6 | 3.8 | 4.1 |
Question 4 : How much money is the company raising and why?
In the IPO, the company is offering 27.90 Lakh shares, Priced at INR 128-135 per share, aggregating to total of INR 37.67 cr, with a lot size of 1000 shares. For the purpose of:
Funding of expenses proposed to be incurred towards registration in Bolvia, South America – INR 1.29 Cr
Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises – INR 5.23 Cr
Advertising, marketing and brand building – INR 4.95 Cr
Investment in procuring hardware and software – INR 0.7 Cr
Funding of working capital requirements – INR 19.75 Cr
General Corporate Purpose
Question 5: Valuation of the company and comparison with other companies.
Particulars | Market Cap | P/E |
Astonea Labs Ltd | 142 | 28x |
Beta Drugs Ltd | 1,787 | 29x |
Question 6: Summary of outstanding Litigaitons
Criminal Proceeding against the company
As on the date of this Red Herring Prospectus, there are no outstanding criminal proceedings initiated against the company

Strengths:
- Diverse Product Portfolio:
Offers a wide range of pharmaceutical and cosmeceutical products, including tablets, capsules, ointments, creams, and more. - Strong Manufacturing Capabilities:
WHO-GMP, ISO, CE, HALAL, and ECO CERT certified facilities, ensuring global compliance and quality assurance. - Experienced Promoter:
Founder Ashish Gulati brings international technical education and strategic vision to the company. - Third-Party Manufacturing Expertise:
Well-established in contract manufacturing, enabling asset-light growth and scalability. - Focus on Sustainability:
Operates a zero-liquid discharge facility and follows eco-friendly manufacturing practices. - Custom Formulation and R&D Capabilities:
In-house R&D supports innovation and product differentiation through novel molecules and advanced packaging.
Weaknesses:
- Limited Brand Recognition (B2C):
Mainly a third-party manufacturer, which limits direct consumer brand visibility. - Dependence on Client Orders:
Contract manufacturing model relies heavily on the continuity and volume of client partnerships. - Regulatory Risks:
Operates in a highly regulated industry; any lapses in compliance could impact operations. - Competition:
Faces intense competition from established pharmaceutical and cosmeceutical manufacturers. - Geographic Concentration:
Primarily based in Haryana, which may limit diversification of manufacturing risks and logistic efficiencies.
🏢 Astonea Labs Limited
- Registered Office Address:
SCO 186–187, 2nd Floor, Cabin No. 206, Sector 8C, Chandigarh – 160009, India - IPO Correspondence Address:
SCO 331, Second Floor, Sector 9, Panchkula, Haryana – 134113, India - Phone: +91 98883 02323
- Email: [email protected]
- Website: www.astonea.org
🗂️ Registrar to the IPO (RTA)
- Name: KFin Technologies Limited
- Address:
Selenium Tower B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500032, Telangana, India - Phone: +91 40 6716 2222 / 1800 309 4001
- Email: [email protected]
- Website: www.kfintech.com
FAQs – Astonea Labs IPO
1. What does Astonea Labs do?
Astonea Labs is a pharmaceutical and cosmeceutical contract manufacturing company. It produces tablets, capsules, ointments, creams, powders, and lotions for other brands, and also works on formulation development and R&D.
2. When is the Astonea Labs IPO opening?
The IPO date will be confirmed in the official prospectus and exchange announcements. Please refer to the latest updates from SEBI or the stock exchanges.
3. What is the price band for the Astonea Labs IPO?
The price band will be specified in the Red Herring Prospectus (RHP). Investors should check stock exchange notifications or financial portals for updates.
4. Is Astonea Labs a listed company?
As of now, Astonea Labs is not listed. The company is coming out with an IPO to get listed on a recognized stock exchange.
5. Who is the registrar for the Astonea Labs IPO?
KFin Technologies Limited is the official registrar handling the IPO processing and allotment.
6. Where is the company based?
Astonea Labs has its registered office in Chandigarh and operational facilities in Panchkula, Haryana.
7. How can I apply for the Astonea Labs IPO?
You can apply through your broker’s platform, UPI-based apps (like Zerodha, Groww, Upstox), or net banking using the ASBA (Application Supported by Blocked Amount) facility.
8. Is Astonea Labs a good investment?
Investment decisions should be based on your personal risk profile. While the company has strengths in manufacturing and certifications, investors should review the RHP, business model, and risks before investing.
9. What is the minimum lot size to apply?
The minimum lot size will be defined in the IPO offer document and typically ranges based on the share price.
10. How do I check my allotment status?
Allotment status can be checked on the KFintech website or the BSE/NSE IPO status page using your PAN, application number, or DP ID.